Earnings History Data for Affimed N.V. (AFMD) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Affimed N.V.
Affimed N.V is a clinical stage biopharmaceutical company. It is engaged in developing single and combination therapies to treat cancers. The company's product pipeline consists of AFM13, AFM24, AFM26, AFM11 and AMV564 which are in clinical stage. Affimed N.V, formerly known as Affimed Therapeutics B.V., is based in Heidelberg, Germany.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 28-03-2024 | PM | AFMD | Affimed N.V. | 79.45 | N/A | -1.59 | -2.20 | Affimed GAAP EPS of -€7.09, revenue of €8.28M [3/28/2024 6:36 AM] |
5.30 | -0.03 (-0.47%) |
5.40 | 0.07 (1.31%) |
2.23 - 11.10 | 71,729 | 100,000 | 1,033 | ||
| 14-11-2023 | PM | AFMD | Affimed N.V. | 47.48 | -0.17 | -0.21 | -0.11 | Affimed GAAP EPS of -€0.16, revenue of €1.96M [11/14/2023 6:33 AM] |
0.3191 | -0.01 (-2.74%) |
0.35 | 0.02 (6.98%) |
0.22 - 2.51 | 601,983 | 670,000 | 14,204 | ||
| 10-08-2023 | PM | AFMD | Affimed N.V. | 86.50 | -0.22 | -0.22 | -0.14 | Affimed GAAP EPS of -€0.20, revenue of €1.4M [8/10/2023 6:57 AM] |
0.5391 | -0.02 (-3.73%) |
0.56 | 0.0 (0.18%) |
0.45 - 3.38 | 489,798 | 710,000 | 2,399 | ||
| 23-05-2023 | PM | 6:30 AM ET (May 23) |
AFMD | Affimed N.V. | 144.47 | -0.23 | -0.22 | -0.16 | Affimed GAAP EPS of -€0.21, revenue of €4.51M [5/23/2023 6:33 AM] |
0.9689 | -0.10 (-9.45%) |
1.06 | -0.01 (-0.93%) |
0.55 - 3.40 | 1,365,966 | 630,000 | 82,035 | |
| 23-03-2023 | PM | 6:30 AM ET (Mar 23) |
AFMD | Affimed N.V. | 144.41 | -0.22 | -0.20 | -0.22 | Affimed GAAP EPS of -€0.60, revenue of €41.35M [3/23/2023 6:32 AM] |
0.6939 | -0.06 (-7.43%) |
0.83 | 0.08 (10.26%) |
0.68 - 5.10 | 1,534,727 | 870,000 | 14,363 | |
| 15-11-2022 | PM | 6:30 AM ET (Nov 15) |
AFMD | Affimed N.V. | 324.07 | -0.11 | -0.19 | -0.17 | Affimed GAAP EPS of -€0.11, revenue of €14.9M [11/15/2022 6:32 AM] |
2.31 | 0.27 (12.99%) |
2.27 | 0.23 (11.27%) |
1.40 - 7.35 | 2,465,147 | 3,030,000 | 29,197 | |
| 11-08-2022 | PM | 6:30 AM ET (Aug 11) |
AFMD | Affimed N.V. | 441.98 | -0.14 | -0.18 | -0.19 | Affimed GAAP EPS of -€0.13, revenue of €7.3M [8/11/2022 6:32 AM] |
3.02 | -0.29 (-8.76%) |
3.10 | -0.21 (-6.34%) |
2.23 - 7.35 | 1,498,880 | 780,000 | 16,155 | |
| 01-06-2022 | PM | 6:30 AM ET (Jun 1) |
AFMD | Affimed N.V. | 470.36 | -0.16 | -0.18 | 0.01 | Affimed GAAP EPS of -€0.14, revenue of €8.02M [6/1/2022 6:33 AM] |
3.12 | 0.03 (0.81%) |
3.16 | 0.06 (1.94%) |
2.88 - 9.03 | 1,390,524 | 1,290,000 | 12,531 | |
|
||||||||||||||||||
| 31-03-2022 | PM | 6:30 AM ET (Mar 31) |
AFMD | Affimed N.V. | 527.11 | -0.22 | -0.17 | -0.20 | Affimed GAAP EPS of -€0.48, revenue of €40.37M [3/31/2022 6:34 AM] |
4.34 | 0.07 (1.52%) |
4.40 | 0.12 (2.80%) |
3.59 - 11.74 | 2,146,064 | 1,130,000 | 7,023 | |
| 10-11-2021 | PM | 6:30 AM ET (Nov 10) |
AFMD | Affimed N.V. | 809.39 | -0.17 | -0.13 | -0.08 | Affimed reports Q3 results [11/10/2021 6:43 AM] |
5.65 | -0.58 (-9.31%) |
5.60 | -0.63 (-10.11%) |
3.75 - 11.74 | 2,368,683 | 2,080,000 | 242,479 | |
|
||||||||||||||||||
| 08-09-2021 | PM | 6:30 AM ET (Sep 8) |
AFMD | Affimed N.V. | 842.19 | -0.19 | -0.06 | -0.18 | Affimed reports Q2 results [9/8/2021 6:40 AM] |
6.80 | 0.07 (0.96%) |
6.85 | 0.11 (1.63%) |
3.08 - 11.74 | 2,186,082 | 1,180,000 | 9,317 | |
|
||||||||||||||||||
| 01-07-2021 | PM | 6:30 AM ET (Jul 1) |
AFMD | Affimed N.V. | 980.17 | 0.01 | -0.08 | -0.12 | Affimed EPS beats by €0.09, beats on revenue [7/1/2021 6:34 AM] |
7.57 | -0.93 (-10.94%) |
7.75 | -0.75 (-8.82%) |
3.07 - 11.74 | 8,078,081 | 1,120,000 | 225,449 | |
| 10-11-2020 | PM | 6:30 AM ET (Nov 10) |
AFMD | Affimed N.V. | 307.56 | -0.08 | -0.12 | -0.19 | Affimed EPS beats by €0.01, beats on revenue [11/10/2020 6:35 AM] |
4.21 | 0.48 (12.87%) |
3.85 | 0.12 (3.22%) |
1.42 - 4.91 | 4,458,853 | 1,007,590 | 103,685 | |
|
|
||||||||||||||||||
| 11-08-2020 | PM | 6:30 AM ET (Aug 11) |
AFMD | Affimed N.V. | 290.51 | -0.18 | -0.12 | -0.16 | Affimed EPS misses by €0.04, misses on revenue [8/11/2020 6:34 AM] |
3.53 | -0.32 (-8.31%) |
3.76 | -0.09 (-2.34%) |
1.42 - 4.91 | 1,212,079 | 1,012,236 | 19,236 | |
|
|
||||||||||||||||||
| 23-06-2020 | PM | 6:35 AM ET (Jun 23) |
AFMD | Affimed N.V. | 295.85 | -0.12 | -0.11 | 0.03 | Affimed EPS beats by €0.01, beats on revenue [6/23/2020 6:34 AM] |
4.28 | -0.12 (-2.83%) |
4.20 | -0.21 (-4.76%) |
1.42 - 4.66 | 887,393 | 2,271,822 | 62,481 | |
|
|
||||||||||||||||||